These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24992394)

  • 21. Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know.
    Maselli DJ; Amalakuhan B; Keyt H; Diaz AA
    Int J Clin Pract; 2017 Feb; 71(2):. PubMed ID: 28238229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
    Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
    Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhaled antibiotics in the treatment of noncystic fibrosis bronchiectasis].
    Martínez García MÁ; Soler Cataluña JJ; Serra PC
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():19-23. PubMed ID: 21703475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis.
    Goeminne PC; Nawrot TS; Ruttens D; Seys S; Dupont LJ
    Respir Med; 2014 Feb; 108(2):287-96. PubMed ID: 24445062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using Cystic Fibrosis Therapies for Non-Cystic Fibrosis Bronchiectasis.
    ElMaraachli W; Conrad DJ; Wang AC
    Clin Chest Med; 2016 Mar; 37(1):139-46. PubMed ID: 26857775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.
    Hill AT; Haworth CS; Aliberti S; Barker A; Blasi F; Boersma W; Chalmers JD; De Soyza A; Dimakou K; Elborn JS; Feldman C; Flume P; Goeminne PC; Loebinger MR; Menendez R; Morgan L; Murris M; Polverino E; Quittner A; Ringshausen FC; Tino G; Torres A; Vendrell M; Welte T; Wilson R; Wong C; O'Donnell A; Aksamit T;
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28596426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based management guidelines for noncystic fibrosis bronchiectasis in children and adolescents.
    Lee E; Kim K; Jeon YH; Sol IS; Kim JD; Min TK; Hwang YH; Cho HJ; Suh DI; Kim HS; Kim YH; Woo SI; Lee YJ; Jung S; Yang HJ; Jang GC
    Clin Exp Pediatr; 2024 Sep; 67(9):418-426. PubMed ID: 38271987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Bergin DA; Hurley K; Mehta A; Cox S; Ryan D; O'Neill SJ; Reeves EP; McElvaney NG
    J Inflamm Res; 2013; 6():1-11. PubMed ID: 23426081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.
    Daviskas E; Anderson SD; Eberl S; Young IH
    Respir Med; 2010 Nov; 104(11):1645-53. PubMed ID: 20576419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled Medications for Maintenance Therapy in Pediatric Noncystic Fibrosis Bronchiectasis.
    Harvath Gray EM; Pettit RS; Engdahl S
    Ann Pharmacother; 2024 Sep; ():10600280241279602. PubMed ID: 39297217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchiectasis: an update on current pharmacotherapy and future perspectives.
    Sidhu MK; Mandal P; Hill AT
    Expert Opin Pharmacother; 2014 Mar; 15(4):505-25. PubMed ID: 24410485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasis.
    Liu J; Zhong X; He Z; Wei L; Zheng X; Zhang J; Bai J; Zhong W; Zhong D
    Mediators Inflamm; 2014; 2014():708608. PubMed ID: 25580060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
    Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
    Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea.
    Wills PJ; Hall RL; Chan W; Cole PJ
    J Clin Invest; 1997 Jan; 99(1):9-13. PubMed ID: 9011581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.
    Gjoerup J; Hilberg O; Bendstrup E
    Respirology; 2012 Aug; 17(6):927-32. PubMed ID: 22564014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical challenges in managing bronchiectasis.
    Tsang KW; Bilton D
    Respirology; 2009 Jul; 14(5):637-50. PubMed ID: 19659645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-cystic fibrosis bronchiectasis.
    McShane PJ; Naureckas ET; Tino G; Strek ME
    Am J Respir Crit Care Med; 2013 Sep; 188(6):647-56. PubMed ID: 23898922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, Radiological, and Microbiologic Characteristics of Patients with Noncystic Fibrosis Bronchiectasis in a Tertiary Center at Jordan.
    Albtoosh AS; Altarawneh T; Toubasi AA; Malek M; Albulbol DM; Alnugaimshi SF; Altarawneh A; Alsurkhi RH; Al Oweidat K; Farah RI; Obeidat N; Salem Albtoush ES
    Curr Med Imaging; 2024; 20():1-8. PubMed ID: 38389348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing drug therapies in bronchiectasis.
    Sidhu MK; Mandal P; Hill AT
    Expert Opin Investig Drugs; 2015 Feb; 24(2):169-81. PubMed ID: 25307313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and prognostic value of osteoporosis in hospitalized patients with bronchiectasis.
    Zou X; Ma Z; Liu X; Zhang K; Qiu C; Liang R; Weng D; Xie L; Cao X; Wu Y; Wen L
    BMC Pulm Med; 2023 Feb; 23(1):55. PubMed ID: 36747237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.